Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MA 05 - Immuno-Oncology: Novel Biomarker Candidates
- 15:45 - 17:30
- 10/16/2017
- Location: Room 303 + 304
- Type: Mini Oral
- Track: Immunology and Immunotherapy
- Moderators:Yoichi Nakanishi, P. Mitchell
-
+
MA 05.01 - Integrating INDEL Mutations into Neoantigen Prediction in Lung Cancer: Developing Personalized Cancer Vaccines
15:45 - 15:50 | Presenter: Yanyan Lou | Author(s): Y. Asmann, M. Thomas, K. Knutson
- Abstract
Loading... -
+
MA 05.02 - STK11/LKB1 Loss of Function Genomic Alterations Predict Primary Resistance to PD-1/PD-L1 Axis Blockade in KRAS-Mutant NSCLC
15:50 - 15:55 | Presenter: Ferdinandos Skoulidis | Author(s): L.A. Albacker, M.D. Hellmann, M.M. Awad, Justin F Gainor, M.E. Goldberg, A.B. Schrock, L. Gay, J. Elvin, Jeffrey S. Ross, H. Rizvi, B. Carter, J. Erasmus, D.F. Halpenny, A. Plodkowski, N. Long, M. Nishino-Habatu, W.L. Denning, J. Rodriguez-Canales, P. Villalobos, E.R. Parra Cuentas, L.M. Sholl, J.L. Sauter, Y.Y. Elamin, Jianjun Zhang, G.C. Leonardi, Kwok-Kin Wong, P.J. Stephens, Vassiliki A Papadimitrakopoulou, Ignacio I. Wistuba, J.D. Wolchok, Alice Shaw, Pasi A Jänne, Charles M Rudin, V.A. Miller, John V Heymach
- Abstract
Loading... -
+
MA 05.03 - The Early Monitoring of Derived Neutrophil-To Lymphocyte Ratio (dNLR) Could Be a Surrogate Marker of Benefit of Immunotherapy in NSCLC
15:55 - 16:00 | Presenter: Laura Mezquita | Author(s): E. Auclin, M. Charrier, Roberto Ferrara, C. Caramella, David Planchard, S. Ponce, Luis Paz-Ares, C. Audigier-Valette, L. Tessonnier, G. Martinez, G. Zalcman, J. Lahmar, J. Remon, J. Adam, N. Chaput, J. Soria, Benjamin Besse
- Abstract
Loading... -
+
MA 05.04 - Distinct Immunosuppressive Microenvironment Determines Poor Prognosis of Nonsmokers with Adenocarcinoma of Non-Small Cell Lung Cancer
16:00 - 16:05 | Presenter: Tomonari Kinoshita | Author(s): T. Fujita, Y. Hayashi, Takashi Ohtsuka, Tetsuya Mitsudomi, Hisao Asamura, Kazuhiro Yasufuku, Y. Kawakami
- Abstract
Loading... -
+
MA 05.05 - Discussant - MA 05.01, MA 05.02, MA 05.03, MA 05.04
16:05 - 16:20 | Presenter: Laura Q Chow
- Abstract
No abstract available for this presentation
-
+
MA 05.06 - Comparison Study of PD-L1 Immunohistochemistry Assays with 22C3 and 28-8: Analysis on Surgical Specimens of NSCLC.
16:20 - 16:25 | Presenter: Tomohito Saito | Author(s): K. Tsuta, M. Ishida, H. Ryota, Y. Takeyasu, K.J. Fukumoto, H. Matsui, Y. Taniguchi, H. Yanagimoto, T. Yokoi, T. Kurata, T. Murakawa
- Abstract
Loading... -
+
MA 05.07 - Whole Body PD-1 and PD-L1 PET in Pts with NSCLC
16:25 - 16:30 | Presenter: J. De Langen | Author(s): Anna-Larissa Nadia Niemeijer, Egbert F Smit, G.A. Van Dongen, A.D. Windhorst, M.C. Huisman, N. Hendrikse, I. Bahce, D.K. Lueng, R.A. Smith, W. Hayes, L.M. Wilson, S.J. Bonacorsi, D.J. Donnelly, P.E. Morin, A. Poot, D.J. Vugts, Erik Thunnissen
- Abstract
Loading... -
+
MA 05.08 - Very Early Response of Circulating Tumor Derived DNA Predict the Efficacy of Treatment by Nivolumab in Patients with Non-small Cell Lung Cancer
16:30 - 16:35 | Presenter: Yuki Iijima | Author(s): T. Nakagomi, Y. Uchida, Y. Kobayashi, T. Tsutsui, Y. Kakizaki, Taichiro Goto, Y. Miyashita
- Abstract
Loading... -
+
MA 05.09 - Pre-Existing Immunity Measured by Teff Gene Expression in Tumor Tissue is Associated with Atezolizumad Efficacy in NSCLC
16:35 - 16:40 | Presenter: Marcin Kowanetz | Author(s): W. Zou, M. McCleland, David R. Gandara, Shirish M Gadgeel, A. Rittmeyer, Fabrice Barlesi, Keunchil Park, D.S. Shames, H. Koeppen, M. Ballinger, A. Sandler, P. Hegde
- Abstract
Loading... -
+
MA 05.10 - Discussant - MA 05.06, MA 05.07, MA 05.08, MA 05.09
16:40 - 16:55 | Presenter: David Rimm
- Abstract
No abstract available for this presentation
-
+
MA 05.11 - Endothelial Adhesion Molecule Overexpression Correlates to Decreased CD8 T Cells and Increased B/Treg Cells in Lung Cancer
16:55 - 17:00 | Presenter: Young Kwang Chae | Author(s): Wooyoung Monica Choi, W.H. Bae, J. Anker, A.A. Davis, Wade Thomas Iams, M. Cruz, M. Matsangou, F.J. Giles
- Abstract
Loading... -
+
MA 05.12 - Oncogenic Drivers Induce Production of CCL5 to Recruit Regulatory T-Cells Early in Lung Cancer Progression
17:00 - 17:05 | Presenter: William W Lockwood | Author(s): E. Franks, E. Halvorsen, E. Melesse, A. Unni, J. Collier, M.H. Oh, V. Lam, G. Krystal, J.C. English, W.L. Lam, Stephen Lam, N. Abraham, K.L. Bennewith
- Abstract
Loading... -
+
MA 05.13 - Scavenger Receptor MARCO Defines a Targetable Tumor-Associated Macrophage Subset in Lung Cancer
17:05 - 17:10 | Presenter: Linnea La Fleur | Author(s): V. Boura, A. Berglund, Johanna Sofia Margareta Mattsson, Dijana Djureinovic, J. Persson, H. Brunnström, J. Isaksson, E. Branden, H. Koyi, Patrick Micke, M. Karlsson, J. Botling
- Abstract
Loading... -
+
MA 05.14 - Differential Expression of IFN-Stimulating DNA Sensors STING and cGAS in Lung Cancer Subtypes
17:10 - 17:15 | Presenter: Charles Caldwell Jr | Author(s): Hui Yu, K. Ellison, L. Rozeboom, C.J. Rivard, Fred R. Hirsch
- Abstract
Loading... -
+
MA 05.15 - Discussant - MA 05.11, MA 05.12, MA 05.13, MA 05.14
17:15 - 17:30 | Presenter: Hiroyuki Suzuki
- Abstract
No abstract available for this presentation
-
+
MA 06 - Lung Cancer Biology I
- 15:45 - 17:30
- 10/16/2017
- Location: Room 501
- Type: Mini Oral
- Track: Biology/Pathology
- Moderators:N. Motoi, Keith M Kerr
-
+
MA 06.01 - Cancer Testis Antigens and Mutational Load in Relation to the Immune Landscape of Non-Small Cell Lung Cancer
15:45 - 15:50 | Presenter: Patrick Micke | Author(s): M.W. Backman, P. Kurppa, Dijana Djureinovic, Linnea La Fleur, J. Persson, Johanna Sofia Margareta Mattsson, J. Botling, E. Branden, H. Koyi, F. Ponten
- Abstract
Loading... -
+
MA 06.02 - Cytology and Surgical Pathology Specimens are Comparable Testing Substrates for PD-L1 Immunohistochemistry in Lung Cancer
15:50 - 15:55 | Presenter: Paul Andrew Vanderlaan | Author(s): V. Torous, D. Rangachari, D.B. Costa
- Abstract
Loading... -
+
MA 06.03 - Programmed Death-Ligand 1 (PD-L1) Expression in Clinical Practice: Comparison of Temporally or Spatially Separated Test Results
15:55 - 16:00 | Presenter: Charuhas Deshpande | Author(s): K. Patel, L. Litzky
- Abstract
Loading... -
+
MA 06.04 - Development of Next-Generation Sequencing Based Cancer Panel and Its Clinical Implications in Lung Cancer
16:00 - 16:05 | Presenter: Yoohwa Hwang | Author(s): Kwanyong Hyun, S. Im, N. Kwon, Y.J. Jung, S.B. Lee, Y.H. Kim, S. Park, H.J. Lee, In Kyu Park, Chang Hyun Kang, Young Tae Kim
- Abstract
Loading... -
+
MA 06.05 - Discussant - MA 06.01, MA 06.02, MA 06.03, MA 06.04
16:05 - 16:20 | Presenter: Giuseppe Giaccone
- Abstract
No abstract available for this presentation
-
+
MA 06.06 - Assessment of RANK Prevalence and Clinical Significance in the NSCLC European Thoracic Oncology Platform Lungscape Cohort
16:20 - 16:25 | Presenter: Erik Thunnissen | Author(s): U. Dafni, Lukas Bubendorf, A. Warth, W. Biernat, S. Pokharel, Rafal Dziadziuszko, H. Dienemann, R. Cheney, N. Marti, M. Kassapian, Stephen P Finn, Keith M Kerr, R. Kammler, Rolf A Stahel, Solange Peters, F. Etop Lungscape
- Abstract
Loading... -
+
MA 06.07 - JAK Pseudokinase Domain Variants Highlight nRTK nsSNPs Identified with Next-Generation Sequencing in NSCLC Patients
16:25 - 16:30 | Presenter: Matthew K Stein | Author(s): L.K. Morris, M.G. Martin
- Abstract
Loading... -
+
MA 06.08 - Lung Cancer Patients with Germline Mutation: A Retrospective Study
16:30 - 16:35 | Presenter: Sandipkumar Patel | Author(s): T. Shukuya, K. Shane-Carson, K. He, E. Bertino, K. Shilo, G. Otterson, David P Carbone
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA 06.10 - Discussant - MA 06.06, MA 06.07, MA 06.08, MA 06.09
16:40 - 16:55 | Presenter: K. Soejima
- Abstract
No abstract available for this presentation
-
+
MA 06.11 - Distinct Mutational Landscape and Evolutionary Trajectories of Brain Metastasis and Liver Metastasis in Lung Adenocarcinoma
16:55 - 17:00 | Presenter: Tao Jiang | Author(s): B. Du, Caicun Zhou
- Abstract
Loading... -
+
- Abstract
Loading... -
+
MA 06.13 - Direct Metabolomic Profiling of Lung Cancers
17:05 - 17:10 | Presenter: Elizabeth Starren | Author(s): J. McDonough, Andrew G Nicholson, M. Moffatt, W. Cookson
- Abstract
Loading... -
+
MA 06.14 - Oncogenic SOS1 Mutations in Lung Adenocarcinoma
17:10 - 17:15 | Presenter: Diana Cai | Author(s): P.S. Choi, Matthew Meyerson
- Abstract
Loading... -
+
MA 06.15 - Discussant - MA 06.11, MA 06.12, MA 06.13, MA 06.14
17:15 - 17:30 | Presenter: Akihiko Yoshida
- Abstract
No abstract available for this presentation
-
+
MS 05 - Clinical Issues of Immune Checkpoint Inhibitors
- 15:45 - 17:30
- 10/16/2017
- Location: Main Hall
- Type: Mini Symposium
- Track: Immunology and Immunotherapy
- Moderators:Luis E Raez, Nico Van Zandwijk
-
+
MS 05.01 - How to Evaluate the Efficacy of IO?
15:45 - 16:00 | Presenter: Frances A Shepherd
- Abstract
No abstract available for this presentation
-
+
MS 05.02 - First-line versus Second-Line Anti-PD-(L)1 Therapy for Patients with Positive PD-L1 Expression
16:00 - 16:15 | Presenter: Fabrice Barlesi
- Abstract
Loading... -
+
MS 05.03 - Rational IO/IO Combinations
16:15 - 16:30 | Presenter: Tony SK Mok
- Abstract
No abstract available for this presentation
-
+
MS 05.04 - Practical Approach to Combination of Chemotherapy with IO
16:30 - 16:45 | Presenter: Yuichiro Ohe
- Abstract
Loading... -
+
MS 05.05 - Continuation of Immunotherapy in Post-Progressive Disease
16:45 - 17:00 | Presenter: David R. Gandara
- Abstract
No abstract available for this presentation
-
+
MS 05.06 - Brain Metastasis: Rationale and Efficacy with IO
17:00 - 17:15 | Presenter: Ignacio Gil-Bazo
- Abstract
Loading... -
+
MS 05.07 - Q&A
17:15 - 17:30
- Abstract
No abstract available for this presentation
-
+
MS 06 - Combined Modality Treatment for Thymic and Pleural Malignancy
- 15:45 - 17:30
- 10/16/2017
- Location: F201 + F202 (Annex Hall)
- Type: Mini Symposium
- Track: Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
- Moderators:Oscar Arrieta, Scott Swanson
-
+
MS 06.01 - Proposal of Change for Future Staging System for Thymic Tumor
15:45 - 16:00 | Presenter: Meinoshin Okumura
- Abstract
Loading... -
+
MS 06.02 - Is There a Role for Minimally Invasive Surgery in Locally Advanced Thymic Tumors?
16:00 - 16:15 | Presenter: Wentao Fang | Author(s): Z. Gu
- Abstract
Loading... -
+
MS 06.03 - PD vs. EPP in the Treatment of MPM
16:15 - 16:30 | Presenter: David Rice
- Abstract
Loading... -
+
MS 06.04 - The Effect of the Timing of Chemotherapy: Induction vs Adjuvant after PD or EPP
16:30 - 16:45 | Presenter: David Waller
- Abstract
Loading... -
+
MS 06.05 - The Use of Adjuvant IMRT after Pleurectomy/Decortication
16:45 - 17:00 | Presenter: Andreas Rimner
- Abstract
Loading... -
+
MS 06.06 - Chemotherapy for Thymic and Mesothelial Tumors
17:00 - 17:15 | Presenter: Miyako Satouchi
- Abstract
Loading... -
+
MS 06.07 - Q&A
17:15 - 17:30
- Abstract
No abstract available for this presentation
-
+
MS 07 - Neuroendocrine Tumors other than SCLC: Pathology to Patient Management
- 15:45 - 17:30
- 10/16/2017
- Location: F203 + F204 (Annex Hall)
- Type: Mini Symposium
- Track: SCLC/Neuroendocrine Tumors
- Moderators:C. Barrios, Sang-We Kim
-
+
MS 07.01 - Pathology of Neuroendocrine Tumors other than SCLC
15:45 - 16:00 | Presenter: Mary Beth Beasley
- Abstract
Loading... -
+
MS 07.02 - Novel Chemotherapy for LCNEC
16:00 - 16:15 | Presenter: Seiji Niho
- Abstract
Loading... -
+
MS 07.03 - Novel Systemic Therapy for Carcinoid of the Lung
16:15 - 16:30 | Presenter: Primo Lara
- Abstract
Loading... -
+
MS 07.04 - Surgical Treatment for Neuroendocrine Tumors other than SCLC
16:30 - 16:45 | Presenter: Akira Iyoda | Author(s): Yoko Azuma, T. Makino, H. Otsuka, S. Koezuka, N. Tochigi, K. Shibuya, T. Mikami, Kazutoshi Isobe, S. Homma
- Abstract
Loading... -
+
MS 07.05 - ESTS Registration for Neuroendocrine Tumors
16:45 - 17:00 | Presenter: Pier Luigi Filosso | Author(s): F. Guerrera, P. Lyberis, E.L.N.S. Committee
- Abstract
Loading... -
+
MS 07.06 - Which Chemotherapy or Targeted Therapy is Better for Treatment of LCNEC Patients: SCLC-based versus Non-SCLC-based Regimens?
17:00 - 17:15 | Presenter: Sumitra Thongprasert
- Abstract
Loading... -
+
MS 07.07 - Q&A
17:15 - 17:30
- Abstract
No abstract available for this presentation
-
+
MS 08 - Novel Treatment for Mesothelioma
- 15:45 - 17:30
- 10/16/2017
- Location: Room 316
- Type: Mini Symposium
- Track: Mesothelioma
-
+
MS 08.01 - Today's Challenges in MPM Care
15:45 - 16:00 | Presenter: Walter Weder
- Abstract
No abstract available for this presentation
-
+
MS 08.02 - Current Role of RT In MPM
16:00 - 16:15 | Presenter: Anna Wrona
- Abstract
Loading... -
+
MS 08.03 - Basic Science and Surgical Advances in MPM
16:15 - 16:30 | Presenter: Raphael Bueno
- Abstract
No abstract available for this presentation
-
+
MS 08.04 - Immunotherapy in MPM
16:30 - 16:45 | Presenter: Anna Nowak
- Abstract
Loading... -
+
MS 08.05 - New Biological Insights
16:45 - 17:00 | Presenter: Yoshitaka Sekido
- Abstract
Loading... -
+
MS 08.06 - Molecularly Stratified Therapy
17:00 - 17:15 | Presenter: Hedy Lee Kindler
- Abstract
No abstract available for this presentation
-
+
MS 08.07 - Achieving Equitable Access to Novel Treatments for all Patients
17:15 - 17:25 | Presenter: Liz Darlison
- Abstract
Loading... -
+
MS 08.08 - Q&A
17:25 - 17:30
- Abstract
No abstract available for this presentation
-
+
MS 09 - Global Perspectives in Eliminating the Major Cause of Lung Cancer
- 15:45 - 17:30
- 10/16/2017
- Location: Room 315
- Type: Mini Symposium
- Track: Epidemiology/Primary Prevention/Tobacco Control and Cessation
- Moderators:Carolyn Dresler, William Kenneth Evans
-
+
MS 09.01 - Global Tobacco Control
15:45 - 16:00 | Presenter: Emily Stone
- Abstract
Loading... -
+
MS 09.02 - FCTC Implementation around the World
16:00 - 16:15 | Presenter: Geoffrey Fong
- Abstract
Loading... -
+
MS 09.03 - Cost Effectiveness of Smoking Cessation
16:15 - 16:30 | Presenter: Hong Gwan Seo
- Abstract
Loading... -
+
MS 09.04 - Nicotine Dependence and Cessation in Lung Cancer Patients
16:30 - 16:45 | Presenter: Matthew A Steliga
- Abstract
Loading... -
+
MS 09.05 - Holding the Tobacco Industry Accountable in the Era of Novel Tobacco Products
16:45 - 17:00 | Presenter: Yumiko Mochizuki
- Abstract
No abstract available for this presentation
-
+
MS 09.06 - Tobacco Industry Interference in Low and Middle Income Countries
17:00 - 17:15 | Presenter: Nise Yamaguchi
- Abstract
Loading... -
+
MS 09.07 - Implementation of Smoking Cessation Strategies
17:15 - 17:30 | Presenter: Patsy Yates
- Abstract
No abstract available for this presentation
-
+
MS 10 - Evidence Based Care: Interpreting the Research and Enhancing Practice
- 15:45 - 17:30
- 10/16/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Symposium
- Track: Nursing/Palliative Care/Ethics
- Moderators:Caitlin Broderick, Pippa Labuc
-
+
MS 10.01 - Radiotherapy Management
15:45 - 16:05 | Presenter: Mary Duffy
- Abstract
No abstract available for this presentation
-
+
MS 10.02 - Interpreting Published Research
16:05 - 16:25 | Presenter: Angela Mary Tod
- Abstract
Loading... -
+
MS 10.03 - Community Outreach - Engaging in Primary Care
16:25 - 16:45 | Presenter: Lavinia Dobrea
- Abstract
Loading... -
+
MS 10.04 - Pre-Operative Support
16:45 - 17:05 | Presenter: Melissa Culligan
- Abstract
No abstract available for this presentation
-
+
MS 10.05 - Immunotherapy: The Latest
17:05 - 17:25 | Presenter: Beth Eaby-Sandy
- Abstract
Loading... -
+
MS 10.06 - Q&A
17:25 - 17:30
- Abstract
No abstract available for this presentation
-
+
OA 04 - Surgery from Minimal to Radical
- 15:45 - 17:30
- 10/16/2017
- Location: Room 311 + 312
- Type: Oral
- Track: Surgery
-
+
OA 04.01 - Randomised Trial of Systematic Lymph Node Dissection versus Bilateral Mediastinal Lymphadenectomy in Patients with Non-Small Cell Carcinoma
15:45 - 15:55 | Presenter: Jaroslaw Kuzdzal | Author(s): Ł. Hauer, J. Hauer, J. Warmus, P. Kocon, Ł. Trybalski, Z. Grochowski, J. Włodarczyk, Tomasz Gil, T. Smęder
- Abstract
Loading... -
+
OA 04.02 - Feasibility of Pulmonary Resection Following Definitive Chemoradiotherapy for Primary Lung Carcinoma
15:55 - 16:05 | Presenter: Yasuhiro Hida | Author(s): K. Kaga, Tatsuya Kato, M. Aragaki, R. Nakada-Kubota, Y. Yagi, R. Chiba, Y. Matsui
- Abstract
Loading... -
+
- Abstract
Loading... -
+
OA 04.04 - Discussant - OA 04.01, OA 04.02, OA 04.03
16:15 - 16:30 | Presenter: Hiroyasu Yokomise
- Abstract
No abstract available for this presentation
-
+
OA 04.05 - Intermediate Results of ICG Anatomical Segmentectomy Based on the Virtual Segmentectomy Simulation
16:30 - 16:40 | Presenter: Yasuo Sekine | Author(s): D. Kaiho, T. Yun, E. Koh, T. Kamata, F. Ishibashi, T. Toyoda
- Abstract
Loading... -
+
OA 04.06 - Surgeon Practices for Post Resection Lung Cancer Surveillance: Comparisons of STS and ESTS Members
16:40 - 16:50 | Presenter: Leah Backhus | Author(s): P. Bhandari, Cecilia Pompili, A. Brunelli, N. Novoa, K. Naunheim, M. Edwards
- Abstract
Loading... -
+
OA 04.07 - Initial Results of Tubeless Single-Port Thoracoscopic Surgery for Pulmonary Tumor
16:50 - 17:00 | Presenter: Chao-Yu Liu | Author(s): P. Hsu, H. Chien, C. Hsieh
- Abstract
Loading... -
+
OA 04.08 - Is Lobe-Specific Lymph Node Dissection in Clinical N0-1 Non-Small Cell Lung Cancer Adequate for Pathological Nodal Staging
17:00 - 17:10 | Presenter: Apichat Tantraworasin | Author(s): S. Siwachat, N. Lertprasertsuke, S. Kongkarnka, J. Euathrongchit, Y. Wannasopha, N. Tanatip, E. Taioli, S. Saeteng
- Abstract
Loading... -
+
OA 04.09 - Discussant - OA 04.05, OA 04.06, OA 04.07, OA 04.08
17:10 - 17:25 | Presenter: Anthony Kim
- Abstract
No abstract available for this presentation
-
+
OA 05 - Next Generation TKI
- 15:45 - 17:30
- 10/16/2017
- Location: Room 301 + 302
- Type: Oral
- Track: Advanced NSCLC
- Moderators:James Chih-Hsin Yang, Fiona Blackhall
-
+
OA 05.01 - First-Line Dacomitinib versus Gefitinib in Advanced Non-Small-Cell Lung Cancer with EGFR Mutation Subgroups
15:45 - 15:55 | Presenter: Yi-Long Wu | Author(s): Ying Cheng, X. Zhou, K.H. Lee, Kazuhiko Nakagawa, Seiji Niho, F. Tsuji, Rafael Rosell, J. Corral, M.R. Migliorino, A. Pluzanski, R. Linke, E.I. Sbar, T. Wang, H. Zhang, Tony SK Mok
- Abstract
Loading... -
+
OA 05.02 - Osimertinib vs SoC EGFR-TKI as First-Line Treatment in Patients with EGFRm Advanced NSCLC (FLAURA): Plasma ctDNA Analysis
15:55 - 16:05 | Presenter: Jhanelle Elaine Gray | Author(s): Isamu Okamoto, V. Sriuranpong, Johan F. Vansteenkiste, F. Imamura, J.S. Lee, Y. Pang, M. Cobo, K. Kasahara, R. Hodge, Brian B Lentrichia, S. Dearden, Suresh S Ramalingam
- Abstract
Loading... -
+
OA 05.03 - Clinical Activity of ASP8273 in Asian Non-Small Cell Lung Cancer Patients with EGFR Activating and T790M Mutations
16:05 - 16:15 | Presenter: Keunchil Park | Author(s): K. Azuma, C. Tsai, Takashi Seto, H. Nokihara, James Chih-Hsin Yang, Sang-We Kim, H. Murakami, Makoto Nishio, K. Kiura, A. Inoue, K. Takeda, Jin-Hyoung Kang, Hidetoshi Hayashi, T. Nakagawa, Y. Kaneko, R. Akazawa, M. Shimazaki, S. Morita, M. Fukuoka, Kazuhiko Nakagawa
- Abstract
Loading... -
+
OA 05.04 - Discussant - OA 05.01, OA 05.02, OA 05.03
16:15 - 16:30 | Presenter: Mark G Kris
- Abstract
No abstract available for this presentation
-
+
OA 05.05 - Brigatinib in Crizotinib-Refractory ALK+ NSCLC: Updated Efficacy and Safety Results From ALTA, a Randomized Phase 2 Trial
16:30 - 16:40 | Presenter: Myung-Ju Ahn | Author(s): D. Ross Camidge, M. Tiseo, Karen L Reckamp, K.H. Hansen, Sang-We Kim, Rudolf M Huber, Howard L West, H.J. Groen, Maximilian Johannes Hochmair, Natasha B Leighl, Scott N. Gettinger, Corey J Langer, Luis Paz-Ares, Egbert F Smit, E.S. Kim, W. Reichmann, D. Kerstein, D. Kim
- Abstract
Loading... -
+
OA 05.06 - Phase 2 Study of Lorlatinib in Patients with Advanced ALK+/ROS1+ Non-Small-Cell Lung Cancer
16:40 - 16:50 | Presenter: Ben J Solomon | Author(s): Alice Shaw, Sai-Hong Ignatius Ou, Benjamin Besse, Enriqueta Felip, T.M. Bauer, R.A. Soo, A. Bearz, Chia-Chi Lin, J.S. Clancy, A. Abbattista, H. Thurm, G. Peltz, E.T. Masters, J. Martini, L.P. James, Takashi Seto
- Abstract
Loading... -
+
OA 05.07 - Efficacy and Updated Safety of Ceritinib (450 Mg or 600 Mg) with Low-Fat Meal vs 750 Mg Fasted in ALK+ Metastatic NSCLC
16:50 - 17:00 | Presenter: Byoung Chul Cho | Author(s): R. Obermannová, A. Bearz, D. Kim, S. Orlov, G. Borra, Sang-We Kim, Pieter E. Postmus, S.A. Laurie, Keunchil Park, S.L. Geater, A.C. Bettini, K. Osborne, V.Q. Passos, Z. Chen, Rafal Dziadziuszko
- Abstract
Loading... -
+
OA 05.08 - Final Result of Phase I/II Study (AF-001JP) of Alectinib, a Selective CNS-Active ALK Inhibitor, in ALK+ NSCLC Patients (Pts)
17:00 - 17:10 | Presenter: Makoto Nishio | Author(s): K. Kiura, Takashi Seto, Kazuhiko Nakagawa, M. Maemondo, A. Inoue, T. Hida, H. Yoshioka, M. Harada, Yuichiro Ohe, N. Nogami, H. Murakami, K. Takeuchi, S. Inamura, H. Kuriki, T. Shimada, T. Tamura
- Abstract
Loading... -
+
OA 05.09 - Discussant- OA 05.05, OA 05.06, OA 05.07, OA 05.08
17:10 - 17:25 | Presenter: Kentaro Tanaka
- Abstract
No abstract available for this presentation